K. Axcrona Et Al. , "ADT for volume reduction, symptom relief and quality of life improvement in men with prostate cancer: Degarelix versus goserelin plus bicalutamide," EUROPEAN UROLOGY SUPPLEMENTS , vol.11, no.1, 2012
Axcrona, K. Et Al. 2012. ADT for volume reduction, symptom relief and quality of life improvement in men with prostate cancer: Degarelix versus goserelin plus bicalutamide. EUROPEAN UROLOGY SUPPLEMENTS , vol.11, no.1 .
Axcrona, K., Aaltomaa, S., Da Silva, C. M., Ozen, H., Damber, J. E., Tanko, L. B., ... Colli, E.(2012). ADT for volume reduction, symptom relief and quality of life improvement in men with prostate cancer: Degarelix versus goserelin plus bicalutamide. EUROPEAN UROLOGY SUPPLEMENTS , vol.11, no.1.
Axcrona, K. Et Al. "ADT for volume reduction, symptom relief and quality of life improvement in men with prostate cancer: Degarelix versus goserelin plus bicalutamide," EUROPEAN UROLOGY SUPPLEMENTS , vol.11, no.1, 2012
Axcrona, K. Et Al. "ADT for volume reduction, symptom relief and quality of life improvement in men with prostate cancer: Degarelix versus goserelin plus bicalutamide." EUROPEAN UROLOGY SUPPLEMENTS , vol.11, no.1, 2012
Axcrona, K. Et Al. (2012) . "ADT for volume reduction, symptom relief and quality of life improvement in men with prostate cancer: Degarelix versus goserelin plus bicalutamide." EUROPEAN UROLOGY SUPPLEMENTS , vol.11, no.1.
@article{article, author={K. Axcrona Et Al. }, title={ADT for volume reduction, symptom relief and quality of life improvement in men with prostate cancer: Degarelix versus goserelin plus bicalutamide}, journal={EUROPEAN UROLOGY SUPPLEMENTS}, year=2012}